Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00118222 · ClinicalTrials.gov registry record · Phase 3
High Light and Low Light Dose PDT in Glioma
A Phase 3 study, sponsored by Case Comprehensive Cancer Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 1
- Enrollment target
NCT00118222 is a Phase 3 study that has completed, run by Case Comprehensive Cancer Center. The registered enrollment target is 1 participants.
The verdict
NCT00118222, a Phase 3 study, has completed, sponsored by Case Comprehensive Cancer Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1 participants
- Enrollment target
Study Summary
RATIONALE: Photodynamic therapy uses a drug, such as porfimer sodium, that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. Giving photodynamic therapy after surgery may kill any remaining tumor cells. PURPOSE: This randomized clinical trial is studying two different light doses of photodynamic therapy using porfimer sodium to compare how well they work in treating patients who are undergoing surgery for recurrent malignant astrocytoma.
Interventions
- PROCEDURE conventional surgery
- PROCEDURE adjuvant therapy
- DRUG porfimer sodium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2005-03 |
| Est. Completion | 2006-03 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00118222
The ClinicalTrials.gov registry entry for NCT00118222 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which conventional surgery is the first listed.
NCT00118222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00118222 about?
NCT00118222 is a clinical study titled "High Light and Low Light Dose PDT in Glioma". RATIONALE: Photodynamic therapy uses a drug, such as porfimer sodium, that becomes active when it is exposed to a certain kind of light. When the drug is active, tumor cells are killed. Giving photodynamic therapy after surgery may kill any remaining tumor cells. PURPOSE: This randomized clinical t...
What is the current status of trial NCT00118222?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1 participants. The study started on 2005-03. Estimated completion is 2006-03.
What interventions are being tested in trial NCT00118222?
The interventions under investigation include: conventional surgery (PROCEDURE), adjuvant therapy (PROCEDURE), porfimer sodium (DRUG).
Who is sponsoring clinical trial NCT00118222?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.